Development and validation of a nomogram for predicting bone marrow involvement in lymphoma patients based on F-FDG PET radiomics and clinical factors.

Journal: Annals of nuclear medicine
Published Date:

Abstract

OBJECTIVE: This study aimed to develop and validate a nomogram combining F-FDG PET radiomics and clinical factors to non-invasively predict bone marrow involvement (BMI) in patients with lymphoma.

Authors

  • Denglu Lu
    Department of Nuclear Medicine, Liuzhou Workers' Hospital, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, People's Republic of China.
  • Xinyu Zhu
  • Xingyu Mu
    Department of Radiology, Guangxi Medical University Cancer Hospital, Guangxi Clinical Research Center for Imaging Medicine, Guangxi Clinical Key Specialty (Medical Imaging), Key Discipline Development Program (Medical Imaging), Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China.
  • Xiaoqi Huang
    Huaxi MR Research Center (HMRRC) Department of Radiology, West China Hospital Sichuan University, Chengdu, 610041, China. julianahuang@163.com.
  • Feng Wei
    State Key Laboratory of Advanced Materials for Smart Sensing, GRINM Group Co., Ltd., Beijing 100088, China.
  • Lilan Qin
    Department of Nuclear Medicine, Liuzhou Workers' Hospital, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, People's Republic of China.
  • Qixin Liu
    Department of Nuclear Medicine, Liuzhou Workers' Hospital, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, People's Republic of China.
  • Wei Fu
    Department of Information Security, Naval University of Engineering, Wuhan, China.
  • Yanyun Deng
    Department of Nuclear Medicine, Liuzhou Workers' Hospital, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, People's Republic of China.